These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11446767)

  • 1. Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation.
    Moore TT; Potter DE
    Exp Eye Res; 2001 Aug; 73(2):167-78. PubMed ID: 11446767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist.
    Russell KR; Wang DR; Potter DE
    Exp Eye Res; 2000 May; 70(5):675-82. PubMed ID: 10870526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphasic alterations of cAMP levels and inhibition of norepinephrine release in iris-ciliary body by bremazocine.
    Russell KR; Potter DE
    J Pharmacol Exp Ther; 2001 Sep; 298(3):941-6. PubMed ID: 11504788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cAMP accumulation by kappa-receptor activation in isolated iris-ciliary bodies: role of phosphodiesterase and protein kinase C.
    Dortch-Carnes J; Potter DE
    J Pharmacol Exp Ther; 2002 May; 301(2):599-604. PubMed ID: 11961062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8OH-DPAT-Induced ocular hypotension: sites and mechanisms of action.
    Chu TC; Ogidigben MJ; Potter DE
    Exp Eye Res; 1999 Aug; 69(2):227-38. PubMed ID: 10433858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
    Ogidigben M; Chu TC; Potter DE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):822-7. PubMed ID: 7902435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors.
    Chu TC; Wong W; Gluchowski C; Hughes BW; Potter DE
    Curr Eye Res; 1996 Sep; 15(9):943-50. PubMed ID: 8921215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular action of an opioid peptide, DPDPE.
    Wang D; Potter DE
    J Ocul Pharmacol Ther; 1996; 12(2):131-9. PubMed ID: 8773929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular actions of moxonidine: a possible role for imidazoline receptors.
    Ogidigben M; Chu TC; Potter DE
    J Pharmacol Exp Ther; 1994 Jun; 269(3):897-904. PubMed ID: 7912282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa opioid receptor localization and coupling to nitric oxide production in cells of the anterior chamber.
    Russell-Randall KR; Dortch-Carnes J
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5233-9. PubMed ID: 21666232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lisuride acts at multiple sites to induce ocular hypotension and mydriasis.
    Potter DE; Ogidigben MJ; Chu TC
    Pharmacology; 1998 Nov; 57(5):249-60. PubMed ID: 9742290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400.
    Barber A; Bartoszyk GD; Greiner HE; Mauler F; Murray RD; Seyfried CA; Simon M; Gottschlich R; Harting J; Lues I
    Br J Pharmacol; 1994 Mar; 111(3):843-51. PubMed ID: 8019761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-2 adrenergic modulation of norepinephrine secretion in the perfused rabbit iris-ciliary body.
    Jumblatt JE; Liu JG; North GT
    Curr Eye Res; 1987 Jun; 6(6):767-77. PubMed ID: 3038473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sigma1 recognition sites in rabbit iris-ciliary body: topical sigma1-site agonists lower intraocular pressure.
    Bucolo C; Campana G; Di Toro R; Cacciaguerra S; Spampinato S
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1362-9. PubMed ID: 10336527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonists.
    Russell KR; Moore TT; Potter DE
    Neuropeptides; 2001; 35(5-6):232-7. PubMed ID: 12030807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular hypotensive action of topical flunarizine in the rabbit: role of sigma 1 recognition sites.
    Campana G; Bucolo C; Murari G; Spampinato S
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1086-94. PubMed ID: 12438531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms.
    Valdez GR; Platt DM; Rowlett JK; Rüedi-Bettschen D; Spealman RD
    J Pharmacol Exp Ther; 2007 Nov; 323(2):525-33. PubMed ID: 17702903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists.
    Carey GJ; Bergman J
    J Pharmacol Exp Ther; 2001 Apr; 297(1):215-23. PubMed ID: 11259547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine receptor activation modulates intraocular pressure in rabbits.
    Crosson CE
    J Pharmacol Exp Ther; 1995 Apr; 273(1):320-6. PubMed ID: 7714784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
    Yu XC; Wang HX; Pei JM; Wong TM
    J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.